Skip to main content

Research Repository

Advanced Search

Alpha-1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571.

J�rgensen, Heather G; Elliott, Moira A; Allan, Elaine K; Carr, Christine E; Holyoake, Tessa L; Smith, Kevin

Authors

Heather G J�rgensen

Moira A Elliott

Elaine K Allan

Christine E Carr

Tessa L Holyoake

Kevin Smith



Abstract

Despite the efficacy of STI571 (Glivec, Novartis, Basle, Switzerland) in treating chronic myeloid leukemia (CML), drug resistance has already been noted both in vitro and in vivo. As plasma proteins, including alpha-1-acid glycoprotein (AGP), may reduce drug efficacy through binding, AGP was investigated for its ability to interact with STI571.


At all stages of CML, AGP plasma level was significantly higher than in normal controls (P < .05). The glycoprotein was purified from normal plasma and individual chronic myeloid leukemia (CML) patients' plasma by low-pressure chromatography. The influence of 1-acid glycoprotein (AGP), in the presence of STI571, on the proliferation of Philadelphia chromosome-positive (Ph+) cells was examined. Normal AGP, even at supraphysiological concentrations, did not block the effect of STI571 on K562-cell proliferation in vitro. Moreover, CML-derived AGP failed to block the effect of STI571 on Ph+ cells in vitro. Thus, these in vitro findings suggest that AGP will not abrogate the antileukemic activity of STI571.

Citation

Jørgensen, H. G., Elliott, M. A., Allan, E. K., Carr, C. E., Holyoake, T. L., & Smith, K. (2002). Alpha-1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571. Blood, 99, 713-715. https://doi.org/10.1182/blood.V99.2.713

Journal Article Type Article
Publication Date Jan 1, 2002
Deposit Date Jun 30, 2008
Print ISSN 0006-4971
Electronic ISSN 1528-0020
Publisher American Society of Hematology
Peer Reviewed Peer Reviewed
Volume 99
Pages 713-715
DOI https://doi.org/10.1182/blood.V99.2.713
Keywords STI57; chronic myeloid leukemia; alpha-1-acid glycoprotein; 1-acid glycoprotein; Philadelphia chromosome-positive (Ph+);
Public URL http://researchrepository.napier.ac.uk/id/eprint/1672
Publisher URL http://dx.doi.org/0.1182/blood.V99.2.713